Microsomal Enzyme Induction and Clinical Aggravation of Porphyria: The Evaluation of Human Urinary 6β-Hydroxycortisol/Cortisol Ratio as the Index of Hepatic CYP3A4 Activity-Reference-Cited by-同舟云学术

Microsomal Enzyme Induction and Clinical Aggravation of Porphyria: The Evaluation of Human Urinary 6β-Hydroxycortisol/Cortisol Ratio as the Index of Hepatic CYP3A4 Activity

Published:2002-12 Issue:12 Volume:42 Page:1374-1379
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Uejima Etsuko,Takahashi Kyoko,Morisaki Tomoko,Takahashi Koichi,Ohno Masako,Nishida Yuko,Moriya Masayuki,Kaido Misako,Abe Kazuo,Sakoda Saburo,Yanagihara Takehiko,Kurokawa Nobuo,Azuma Junichi

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference29 articles.

1. Safety of anticonvulsants in hepatic porphyries;Reynolds;Neurology,1981

2. Effect of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: potential implications for patients with acute porphyria;Hahn;Neurology,1997

3. Specific determination of urinary 6β-hydroxycortisol and cortisol ratio by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry;Ohno;J Chromatography B,2000

4. Porphyria with double errors in the heme biosynthetic pathway;Kaido;J Neurology,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytochrome P450 3A4 activity and genetic variants as predictors of liver failure in patients with obstructive jaundice;Free Radical Biology and Medicine;2023-11

2. Absence of Drug–Drug Interactions Between Luseogliflozin, a Sodium–Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males;Advances in Therapy;2015-05

3. Evidence from pharmacology and pathophysiology suggests that chemicals with dissimilar mechanisms of action could be of bigger concern in the toxicological risk assessment of chemical mixtures than chemicals with a similar mechanism of action;Regulatory Toxicology and Pharmacology;2014-08

4. Genotype-phenotype variability in human CYP3A locus in Nepalese people residing in Bangladesh;Int. Journal of Clinical Pharmacology and Therapeutics;2013-03-01

5. Study of the Urinary Ratio of 6 β-Hydroxycortisol/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases;Biomarker Insights;2006-01